Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital
Punzalan et al., Frontiers in Immunology, doi:10.3389/fimmu.2023.1123497
https://c19early.org/punzalan.html